High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human

Insights

Most clinical Enterococcus faecalis isolates produce hemolysin, a trait linked to clumping response and drug resistance. Hemolysin determinants are transferable, but not linked to drug resistance genes.

Area of Science:

  • Microbiology
  • Clinical Infectious Diseases

Background:

  • Enterococcus faecalis is an opportunistic pathogen.
  • Hemolysin production and clumping factor are virulence factors in Enterococcus faecalis.

Purpose of the Study:

  • To investigate hemolysin production, clumping response, and drug resistance in clinical isolates of Enterococcus faecalis.
  • To determine the transferability of the hemolytic trait and its association with drug resistance.

Main Methods:

  • Analysis of 97 clinical isolates of Enterococcus faecalis from diverse sources.
  • Assessment of hemolysin production, clumping response, and antibiotic resistance profiles.
  • Evaluation of the transferability of hemolysin determinants.

Main Results:

  • Approximately 60% of isolates were hemolytic.
  • Hemolytic strains showed a higher prevalence of clumping response (85%) compared to nonhemolytic strains (49%).
  • Over 50% of hemolytic strains possessed transferable hemolysin determinants, independent of drug resistance genes. Hemolytic strains were more frequently multidrug-resistant.

Conclusions:

  • Hemolysin production is common in clinical Enterococcus faecalis isolates and associated with clumping factor and increased drug resistance.
  • The hemolytic trait is transferable but not linked to drug resistance genes in these isolates.

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...